Special Report

Department of Biomedical Engineering, College of Engineering, University of Arkansas, Fayetteville, AR 72701, USA

Department of Biological Sciences, Fulbright College of Arts & Sciences, University of Arkansas, Fayetteville, AR 72701, USA

Search for more papers by this author

Raj R Rao

*Author for correspondence:

E-mail Address: rajrao@uark.edu

https://orcid.org/0000-0003-0544-413X

Department of Biomedical Engineering, College of Engineering, University of Arkansas, Fayetteville, AR 72701, USA

Search for more papers by this author

Published Online:5 Mar 2024https://doi.org/10.2217/rme-2023-0230

View article

Abstract

Many vascular disorders arise as a result of dysfunctional smooth muscle cells. Tissue engineering strategies have evolved as key approaches to generate functional vascular smooth muscle cells for use in cell-based precision and personalized regenerative medicine approaches. This article highlights some of the challenges that exist in the field and presents some of the prospects for translating research advancements into therapeutic modalities. The article emphasizes the need for better developing synergetic intracellular and extracellular cues in the processes to generate functional vascular smooth muscle cells from different stem cell sources for use in tissue engineering strategies.

Plain language summary

This paper explores the potential of engineering smooth muscle tissues to treat vascular diseases, focusing on challenges like sourcing the right cells and creating supportive environments for cell growth. It highlights advances in materials that mimic the body's conditions and the use of 3D fabrication methods for creating complex structures. Additionally, it discusses the significance of mitochondrial function in blood vessel muscle cells. The research emphasizes interdisciplinary efforts and personalized treatments as key to developing effective therapies. The goal is to engineer lab-grown tissues that can repair or replace damaged blood vessels, offering hope for addressing major health challenges associated with vascular diseases.

Keywords:

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

1. Vaduganathan M, Mensah GA, Turco JV, Fuster V, Roth GA. The global burden of cardiovascular diseases and risk: a compass for future health. J. Am. Coll. Cardiol. 80(25), 2361–2371 (2022).
MedlineGoogle Scholar
2. Tang HY, Chen AQ, Zhang H, Gao XF, Kong XQ, Zhang JJ. Vascular smooth muscle cells phenotypic switching in cardiovascular diseases. Cells 11(24), 1–15 (2022).
CASGoogle Scholar
3. Nicolas J, Magli S, Rabbachin L, Sampaolesi S, Nicotra F, Russo L. 3D extracellular matrix mimics: fundamental concepts and role of materials chemistry to influence stem cell fate. Biomacromolecules 21(6), 1968–1994 (2020).
Medline CASGoogle Scholar
4. Stevens KR, Murry CE. Human pluripotent stem cell-derived engineered tissues: clinical considerations. Cell Stem Cell 22(3), 294–297 (2018).
Medline CASGoogle Scholar
5. Li N, Sanyour H, Remund T, Kelly P, Hong Z. Vascular extracellular matrix and fibroblasts-coculture directed differentiation of human mesenchymal stem cells toward smooth muscle-like cells for vascular tissue engineering. Mater. Sci. Eng. C Mater. Biol. Appl. 93, 61–69 (2018).
Medline CASGoogle Scholar
6. Harris LJ, Abdollahi H, Zhang P, Mcilhenny S, Tulenko TN, Dimuzio PJ. Differentiation of adult stem cells into smooth muscle for vascular tissue engineering. J. Surg. Res. 168(2), 306–314 (2011).
Medline CASGoogle Scholar
7. Wanjare M, Kuo F, Gerecht S. Derivation and maturation of synthetic and contractile vascular smooth muscle cells from human pluripotent stem cells. Cardiovasc. Res. 97(2), 321–330 (2013).
Medline CASGoogle Scholar
8. Floren M, Bonani W, Dharmarajan A, Motta A, Migliaresi C, Tan W. Human mesenchymal stem cells cultured on silk hydrogels with variable stiffness and growth factor differentiate into mature smooth muscle cell phenotype. Acta Biomater. 31, 156–166 (2016).
Medline CASGoogle Scholar
9. Rim NG, Yih A, Hsi P, Wang Y, Zhang Y, Wong JY. Micropatterned cell sheets as structural building blocks for biomimetic vascular patches. Biomaterials 181, 126–139 (2018).
Medline CASGoogle Scholar
10. Swaminathan G, Gadepalli V, Stoilov I, Mecham RP, Rao RR, Ramamurthi A. Pro-elastogenic effects of bone marrow mesenchymal stem cell-derived smooth muscle cells on cultured aneurysmal smooth muscle cells. J.Tissue Eng. Regener. Med. 11, 679–693 (2017). • Highlights the pro-elastogenic potential of mesenchymal stem cell-derived smooth muscle cells and its ability to contribute to positive elastogenic outcomes on aneurysmal smooth muscle cells.
Medline CASGoogle Scholar
11. Fraser JK, Wulur I, Alfonso Z, Hedrick MH. Fat tissue: an underappreciated source of stem cells for biotechnology. Trends Biotechnol. 24(4), 150–154 (2006).
Medline CASGoogle Scholar
12. Musiał-Wysocka A, Kot M, Majka M. The pros and cons of mesenchymal stem cell-based therapies. Cell Transplant. 28(7), 801–812 (2019).
MedlineGoogle Scholar
13. Shen M, Quertermous T, Fischbein MP, Wu JC. Generation of vascular smooth muscle cells from induced pluripotent stem cells: methods, applications, and considerations. Circ. Res. 128(5), 670–686 (2021).
Medline CASGoogle Scholar
14. Swaminathan G, Stoilov I, Broekelmann T, Mecham R, Ramamurthi A. Phenotype-based selection of bone marrow mesenchymal stem cell-derived smooth muscle cells for elastic matrix regenerative repair in abdominal aortic aneurysms. J. Tissue Eng. Regen. Med. 12(1), e60–e70 (2018).
Medline CASGoogle Scholar
15. Sivaraman S, Hedrick J, Ismail S, Slavin C, Rao RR. Generation and characterization of human mesenchymal stem cell-derived smooth muscle cells. Int. J. Mol. Sci. 22(19), 1–18 (2021). • Details the potential for specific growth factors to generate smooth muscle cells from bone-marrow and adipose derived mesenchymal stem cells.
Google Scholar
16. Bashur CA, Rao RR, Ramamurthi A. Perspectives on stem cell-based elastic matrix regenerative therapies for abdominal aortic aneurysms. Stem Cells Transl. Med. 2(6), 401–408 (2013).
Medline CASGoogle Scholar
17. Stephenson M, Reich DH, Boheler KR. Induced pluripotent stem cell-derived vascular smooth muscle cells. Vasc. Biol. 2(1), R1–R15 (2020).
Medline CASGoogle Scholar
18. Cao G, Xuan X, Hu J, Zhang R, Jin H, Dong H. How vascular smooth muscle cell phenotype switching contributes to vascular disease. Cell Commun. Signal. 20(1), 180 (2022).
MedlineGoogle Scholar
19. Liu S, Lin Z. Vascular smooth muscle cells mechanosensitive regulators and vascular remodeling. J. Vasc. Res. 59(2), 90–113 (2022).
Medline CASGoogle Scholar
20. Jeong SI, Kwon JH, Lim JI et al. Mechano-active tissue engineering of vascular smooth muscle using pulsatile perfusion bioreactors and elastic PLCL scaffolds. Biomaterials 26(12), 1405–1411 (2005).
Medline CASGoogle Scholar
21. Steucke KE, Tracy PV, Hald ES, Hall JL, Alford PW. Vascular smooth muscle cell functional contractility depends on extracellular mechanical properties. J. Biomech. 48(12), 3044–3051 (2015).
MedlineGoogle Scholar
22. Yarbrough D, Gerecht S. Engineering smooth muscle to understand extracellular matrix remodeling and vascular disease. Bioengineering (Basel) 9(9), 449:1–15(2022). • Highlights the importance of in vitro tissue engineering of human vascular smooth muscle towards promoting a better understanding of cardiovascular diseases using high throughput experiments, thus potentially leading to better therapeutic outcomes.
Google Scholar
23. Rosellini E, Barbani N, Lazzeri L, Cascone MG. Biomimetic and bioactive small diameter tubular scaffolds for vascular tissue engineering. Biomimetics (Basel) 7(4), 199:1–19 (2022).
Google Scholar
24. Ryan AJ, O'Brien FJ. Insoluble elastin reduces collagen scaffold stiffness, improves viscoelastic properties, and induces a contractile phenotype in smooth muscle cells. Biomaterials 73, 296–307 (2015). • Highlights the ability of elastin to alter the mechanical and biological response of scaffolds and contributions to development of biomimetic scaffolds for cardiovascular tissue engineering.
Medline CASGoogle Scholar
25. Shin YC, Lee JH, Jin L et al. Stimulated myoblast differentiation on graphene oxide-impregnated PLGA-collagen hybrid fibre matrices. J. Nanobiotechnol. 13, 21 (2015).
MedlineGoogle Scholar
26. Weekes A, Bartnikowski N, Pinto N, Jenkins J, Meinert C, Klein TJ. Biofabrication of small diameter tissue-engineered vascular grafts. Acta Biomater. 138, 92–111 (2022). • Highlights the need for continued advancements in microscale additive manufacturing, biofabrication, tissue engineering and decellularization towards generation of functional tissue engineered vascular grafts.
Medline CASGoogle Scholar
27. Jensen LF, Bentzon JF, Albarrán-Juárez J. The phenotypic responses of vascular smooth muscle cells exposed to mechanical cues. Cells 10(9), 2209:1–20(2021).
Google Scholar
28. Cocciolone AJ, Hawes JZ, Staiculescu MC, Johnson EO, Murshed M, Wagenseil JE. Elastin, arterial mechanics, and cardiovascular disease. Am. J. Physiol. Heart Circ. Physiol. 315(2), H189–H205 (2018).
Medline CASGoogle Scholar
29. Kim BS, Kim H, Gao G, Jang J, Cho DW. Decellularized extracellular matrix: a step towards the next generation source for bioink manufacturing. Biofabrication 9(3), 034104 (2017).
MedlineGoogle Scholar
30. Wolf MT, Daly KA, Reing JE, Badylak SF. Biologic scaffold composed of skeletal muscle extracellular matrix. Biomaterials 33(10), 2916–2925 (2012).
Medline CASGoogle Scholar
31. Kwong G, Marquez HA, Yang C, Wong JY, Kotton DN. Generation of a purified iPSC-derived smooth muscle-like population for cell sheet engineering. Stem Cell Reports 13(3), 499–514 (2019).
Medline CASGoogle Scholar
32. Zhu Y, Thakore AD, Farry JM et al. Collagen-supplemented incubation rapidly augments mechanical property of fibroblast cell sheets. Tissue Eng. Part A 27(5–6), 328–335 (2021).
Medline CASGoogle Scholar
33. Costantini M, Testa S, Mozetic P et al. Microfluidic-enhanced 3D bioprinting of aligned myoblast-laden hydrogels leads to functionally organized myofibers in vitro and in vivo. Biomaterials 131, 98–110 (2017).
Medline CASGoogle Scholar
34. Jeon O, Lee Y-B, Hinton TJ, Feinberg AW, Alsberg E. Cryopresserved cell-laden alginate microgel bioinki for 3D bioprinting of living tissues. Mater. Today Chem. 12, 61–70 (2019).
Medline CASGoogle Scholar
35. Mccormack A, Highley CB, Leslie NR, Melchels FPW. 3D printing in suspension baths: keeping the promises of bioprinting afloat. Trends Biotechnol. 38(6), 584–593 (2020).
Medline CASGoogle Scholar
36. Jeon O, Bin Lee Y, Hinton TJ, Feinberg AW, Alsberg E. Cryopreserved cell-laden alginate microgel bioink for 3D bioprinting of living tissues. Mater. Today Chem. 12, 61–70 (2019).
Medline CASGoogle Scholar
37. Zhou X, Nowicki M, Sun H et al. 3D bioprinting-tunable small-diameter blood vessels with biomimetic biphasic cell layers. ACS Appl. Mater. Interf. 12(41), 45904–45915 (2020).
Medline CASGoogle Scholar
38. Hollister SJ. Porous scaffold design for tissue engineering. Nat. Mater. 4(7), 518–524 (2005).
Medline CASGoogle Scholar
39. Engbers-Buijtenhuijs P, Buttafoco L, Poot AA et al. Biological characterisation of vascular grafts cultured in a bioreactor. Biomaterials 27(11), 2390–2397 (2006).
Medline CASGoogle Scholar
40. Zahedmanesh H, Lally C. A multiscale mechanobiological modelling framework using agent-based models and finite element analysis: application to vascular tissue engineering. Biomech. Model Mechanobiol. 11(3–4), 363–377 (2012).
MedlineGoogle Scholar
41. Armstrong JPK, Stevens MM. Emerging technologies for tissue engineering: from gene editing to personalized medicine. Tissue Eng. Part A 25(9–10), 688–692 (2019).
MedlineGoogle Scholar
42. Zakharova IS, Zhiven MK, Saaya SB et al. Endothelial and smooth muscle cells derived from human cardiac explants demonstrate angiogenic potential and suitable for design of cell-containing vascular grafts. J. Transl. Med. 15(1), 54 (2017).
Medline CASGoogle Scholar
43. Kuznetsov AV, Hermann M, Saks V, Hengster P, Margreiter R. The cell-type specificity of mitochondrial dynamics. Int. J. Biochem. Cell Biol. 41(10), 1928–1939 (2009).
Medline CASGoogle Scholar
44. Xia Y, Zhang X, An P, Luo J, Luo Y. Mitochondrial homeostasis in VSMCs as a central hub in vascular remodeling. Int. J. Mol. Sci. 24(4), 3483:1–15(2023).
Google Scholar
45. Bakare AB, Daniel J, Stabach J et al. Quantifying mitochondrial dynamics in patient fibroblasts with multiple developmental defects and mitochondrial disorders. Int. J. Mol. Sci. 22(12), 6263:1–26(2021).
Google Scholar
46. Bakare AB, Dean J, Chen Q et al. Evaluating the bioenergetics health index ratio in Leigh syndrome fibroblasts to understand disease severity. Int. J. Mol. Sci. 22(19), 10344:1–20(2021).
Google Scholar
47. Bakare AB, Lesnefsky EJ, Iyer S. Leigh syndrome: a tale of two genomes. Front. Physiol. 12, 693734 (2021).
MedlineGoogle Scholar
48. Bakare AB, Meshrkey F, Lowe B et al. MitoCellPhe reveals mitochondrial morphologies in single fibroblasts and clustered stem cells. Am. J. Physiol. Cell Physiol. 321(4), C735–C748 (2021). •• Highlights the potential for comparative mitochondrial morphological analysis in determining differences between normal and diseased cell types in both undifferentiated and differentiated cells.
Medline CASGoogle Scholar
49. Chan DC. Mitochondrial dynamics and its involvement in disease. Annu. Rev. Pathol. 15, 235–259 (2020).
Medline CASGoogle Scholar
50. Vásquez-Trincado C, García-Carvajal I, Pennanen C et al. Mitochondrial dynamics, mitophagy and cardiovascular disease. J. Physiol. 594(3), 509–525 (2016). • Highlights the role of mitochondria and alterations in mitochondrial morphology leading to bioenergetic adaptation during cardiac pathological remodeling.
Medline CASGoogle Scholar
51. Wang L, Yu T, Lee H, O'Brien DK, Sesaki H, Yoon Y. Decreasing mitochondrial fission diminishes vascular smooth muscle cell migration and ameliorates intimal hyperplasia. Cardiovasc. Res. 106(2), 272–283 (2015).
Medline CASGoogle Scholar
52. Chi C, Li DJ, Jiang YJ et al. Vascular smooth muscle cell senescence and age-related diseases: state of the art. Biochim. Biophys. Acta Mol. Basis Dis. 1865(7), 1810–1821 (2019).
Medline CASGoogle Scholar
53. Salabei JK, Cummins TD, Singh M, Jones SP, Bhatnagar A, Hill BG. PDGF-mediated autophagy regulates vascular smooth muscle cell phenotype and resistance to oxidative stress. Biochem. J. 451(3), 375–388 (2013).
Medline CASGoogle Scholar
54. Wang PW, Pang Q, Zhou T et al. Irisin alleviates vascular calcification by inhibiting VSMC osteoblastic transformation and mitochondria dysfunction via AMPK/Drp1 signaling pathway in chronic kidney disease. Atherosclerosis 346, 36–45 (2022).
Medline CASGoogle Scholar
55. James AM, Cochemé HM, Smith RA, Murphy MP. Interactions of mitochondria-targeted and untargeted ubiquinones with the mitochondrial respiratory chain and reactive oxygen species. Implications for the use of exogenous ubiquinones as therapies and experimental tools. J. Biol. Chem. 280(22), 21295–21312 (2005).
Medline CASGoogle Scholar

Vol. 19, No. 3

Metrics

Downloaded 45 times

History

Received 4 December 2023

Accepted 16 February 2024

Published online 5 March 2024

Published in print March 2024

Information

Keywords

Author contributions

CS Baldwin contributed to collecting and reviewing the literature and drafting the article. S Iyer contributed to reviewing the literature and drafting the article; RR Rao contributed to reviewing the literature and drafting the article.

Financial disclosure

Funding was provided by the US Department of Health and Human Services (National Institutes of Health) Eunice Kennedy Shriver National Institute of Child Health and Human Development (1R01HD110536-01A1). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

Competing interests disclosure

The authors have no competing interests or relevant affiliations with any organization or entity with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, stock ownership or options and expert testimony.

Writing disclosure

No writing assistance was utilized in the production of this manuscript.

PDF download

The challenges and prospects of smooth muscle tissue engineering

Abstract

Plain language summary

References